Register entry
- Registered sites
- 2
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- South Korea
Authorisation
Registered operations
Analytical testing2Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Prestige Biologics Co., LtdRegistrant: Prestige Biologics Co., Ltd. | 197 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28161, Korea, South (KOR) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3022076803694466328 |
| Prestige Biologics Co., Ltd. | 56 Osongsaengmyeong 8-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28220, Korea, South (KOR) | Analytical testing, Active ingredient (API) manufacture | 3046540791696554793 |
Neighbours
Registered in the same town
1- Medytox Inc.Chungcheongbuk-do 28161, KOR
Compare
Comparable companies in South Korea
- Englewood Lab Korea Co Ltd2 sites · 11 NDC
- ST Pharm Co., Ltd.2 sites · 8 NDC
- Huons Co., Ltd.2 sites · 5 NDC
- High Tech Pharm Co., Ltd.2 sites · 0 NDC
- Aekyung Industrial Co., Ltd.1 site · 64 NDC
- Amorepacific Group1 site · 53 NDC
- I World Pharmaceutical Co., Ltd.1 site · 48 NDC
- CELLTRION Inc1 site · 36 NDC
- LAON COMMERCE CO LTD1 site · 28 NDC
- TAI GUK PHARM. CO., LTD1 site · 28 NDC
Enquiry
Common questions
- Is Prestige Biologics Co., Ltd. FDA approved?
- Prestige Biologics Co., Ltd. holds 2 FDA-registered establishments in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Prestige Biologics Co., Ltd.'s drugs manufactured?
- The FDA register lists Chungcheongbuk-do 28161; Chungcheongbuk-do 28220. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.